Tumor necrosis factor and interferon activity in the circulation of calves after repeated injection of low doses of lipopolysaccharide

Veterinary Immunology and Immunopathology

Volumn 62, Issue 4, 1998, Pages 297-307

  Bieniek, Kazimierz ^a   Szuster Ciesielska, Agnieszka ^b   Kamińska, Teresa ^b   Kondracki, Marian ^a   Witek, Maria ^b   Kandefer Szerszeń, Martyna ^b  

^a NATIONAL VETERINARY RESEARCH INSTITUTE   (Poland)

^b Inst Microbiol Biotech   (Poland)

Author keywords

Endotoxin tolerance; Interferon; Tumor necrosis factor

Indexed keywords

ENDOTOXIN; INTERFERON; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREATHING; COW; DOSE RESPONSE; HEART RATE; HEMATOCRIT; HYPOGLYCEMIA; IMMUNOLOGICAL TOLERANCE; LEUKOPENIA; NONHUMAN; RECTUM TEMPERATURE;

ANIMALS; BLOOD GLUCOSE; CATTLE; CATTLE DISEASES; DRUG TOLERANCE; ENDOTOXEMIA; ERYTHROCYTE INDICES; FEVER; GRAM-NEGATIVE BACTERIAL INFECTIONS; HEART RATE; HYPOGLYCEMIA; INTERFERONS; LEUKOCYTE COUNT; LEUKOPENIA; LIPOPOLYSACCHARIDES; MALE; RESPIRATION; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 0032580244     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(98)00102-0     Document Type: Article

References (49)

1. Adams J.L., Czuprynski C.J. Bacterial lipopolysaccharide induces release of tumor necrosis factor-α from bovine peripheral blood monocytes and alveolar macrophages in vitro. J. Leukocyte Biol. 48:1990;549-556.
2. Adams J.L., Semrad S.D., Czuprynski C.J. Administration of bacterial lipopolysaccharide elicits circulating tumor necrosis factor-alpha in neonatal calves. J. Clin. Microbiol. 28:1990;998-1001.
3. Allen G.K., Green E.M., Robinson J.A., Garner H.E., Loch W.E., Walsh D.M. Serum tumor necrosis factor alpha concentrations and clinical abnormalities in colostrum-fed and colostrum-deprived neonatal foals given endotoxin. Am. J. Vet. Res. 54:1993;1404-1410.
4. Alving C.R. Lipopolysaccharide, lipid A and liposomes containing lipid A as immunologic adjuvants. Immunobiology. 187:1993;430-446.
5. Beutler B., Cerami A. Cachectin: more than a tumor necrosis factor. New Engl. J. Med. 316:1987;379-385.
6. Beutler B., Milsak I.W., Cerami A. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effects of endotoxin. Science. 229:1985;869-871.
7. Bienhoff S.E., Allen G.K., Berg N. Release of tumor necrosis factor-alpha from bovine alveolar macrophages stimulated with bovine respiratory viruses and bacterial endotoxins. Vet. Immunol. Immunopathol. 30:1992;341-357.
8. Blatteis C.M., Mashburn T.A., Ahokas R.A. Fever and trace metal changes in endotoxin challenged neonates. Pflügers Arch. 389:1984;177-179.
9. Blood, D.C., Henderson, J.A., Radostitis, O.M., 1981. Diseases caused by bacteria. Veterinary Medicine, 5th edn. Williams and Wilkins, Baltimore, pp. 461-471.
10. Cargile J.L., McKay R.J., Dankert J.R., Skelley L. Effect of treatment with a monoclonal antibody against equine tumor necrosis factor (TNF) on clinical, hematologic and circulating TNF responses of Miniature Horses given endotoxin. Am. J. Vet. Res. 56:1995;1451-1459.
11. Chaby R., Girard R. Interaction of lipopolysaccharides with cells of immunological interest. Eur. Cytokine Netw. 4:1993;399-414.
12. Cybulsky M.J., Chan M.K., Movat H.Z. Biology of disease. Acute inflammation and microthrombus induced by endotoxin, interleukin 1, and tumor necrosis factor and their implication in gram negative infection. Lab. Invest. 58:1988;365-379.
13. Deitch E.A. Multiple organ failure - pathophysiology and potential future therapy. Ann. Surg. 216:1992;117-123.
14. Demling R.H., Smith M., Gunter R. Endotoxin-induced lung injury in unanesthetized sheep: effect of methylprednisolone. Circ. Shock. 8:1981;351-360.
15. Elsasser T.H., Richards M., Collier R., Hartnell G.F. Physiological response to repeated endotoxin challenge are selectively affected by recombinant bovine somatotropin administration to calves. Domest. Anim. Endocrinol. 13:1996;91-103.
16. Ertel W., Morrison M.H., Wang P., Ayala A., Choudry J.H. The complex pattern of cytokines in sepsis. Ann. Surg. 214:1991;141-148.
17. Fultz M.J., Barber S.A., Diffenbach C.W., Vogel S.N. Induction of IFN-γ in macrophages by lipopolysaccharide. Int. Immunol. 5:1993;1383-1392.
18. Gerros T.C., Semrad S.D., Proctor R.A., LaBorde A. Effect of dose and method of administration of endotoxin on cell mediator release in neonatal calves. Am. J. Vet. Res. 54:1993;2121-2127.
19. I1 interferon in dairy calves. J. Clin. Microbiol. 24:1986;240-244.
20. Havell E.A., Spitalny G.L. Endotoxin-induced interferon synthesis in macrophage cultures. J. Reticuloendothel. Soc. 33:1983;369-380.
21. Hesse D.G., Tracey K.J., Fong Y., Manogue K.P., Palladino M.A., Cerami A., Shires G.T., Lowry S.F. Cytokine appearance in human endotoxemia and primate bacteremia. Surg. Gynecol. Obstet. 166:1988;147-153.
22. Ho M., Kono Y., Breing M.K. Tolerance to induction of interferons by endotoxin and virus: role of humoral factor. Proc. Soc. Exp. Biol. Med. 119:1965;1227-1232.
23. Hoffman W.D., Natanson C. Endotoxin in septic shock. Anesth. Analg. 77:1993;613-624.
24. Johnson J., Myerick B., Jesmok G., Brigham K.L. Human recombinant tumor necrosis factor alpha infusion mimics endotoxemia in awake sheep. J. Appl. Physiol. 66:1989;1448-1454.
25. Kandefer-Szerszeń M., Filar J., Szuster-Ciesielska A., Rzeski W. Suppression of interferon response of bovine leukocytes during clinical and subclinical ketosis in lactating cows. Dtsch. Tierärztl. Wsch. 99:1992;440-443.
26. Kenison D.C., Elsasser T.H., Fayer R. Tumor necrosis factor as a potent mediator of acute metabolic and hormonal responses to endotoxemia in calves. Am. J. Vet. Res. 52:1991;1320-1326.
27. Kushner, 1988.
28. LeMay L.G., Otterness I., Vander A.J., Kluger M.J. In vivo evidence that the rise in plasma IL-6 following injection of fever-inducing dose of LPS is mediated by IL-1β Cytokine. 2:1990;199-204.
29. Luce J.M. Pathogenesis and management of septic shock. Chest. 91:1987;883-888.
30. Mathison J.C., Wolfson E.W., Ulevitch R.J. Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. J. Clin. Invest. 81:1988;1925-1937.
31. Michaels F.H., Banks K.L. Contribution of various host factors to resistance to experimentally induced bacterial endotoxemia in calves. Am. J. Vet. Res. 49:1988;557-562.
32. Michie H.R., Manique R.R., Spriggs D.R., Revhang A., O'Dwyer S., Dinarello C.A., Cerami A., Milner K.C. Patterns of tolerance to endotoxin. J. Infect. Dis. 128:1973;237-245. suppl.
33. Mossman T. Rapid colorimetric assay for cellular growth and cytotoxicity assay. J. Immunol. Methods. 65:1983;55-63.
34. Natanson C., Eichenholz P.W., Danner R.L., Eichacker P.Q., Hoffman W.D., Kuo G.C., Banks S.M., MacVittie T.J., Parillo J.E. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J. Exp. Med. 169:1989;823-832.
35. Remick D.G., Kunkel R.G., Larrick J.W., Kunkel S.L. Acute in vivo effects of human recombinant tumor necrosis factor. Lab. Invest. 56:1987;583-590.
36. Robinson J.A., Allen C.K., Green E.M., Garner H.E., Loch W.E., Wash D.M. Serum interleukin-6 concentration in endotoxin-infused neonatal foals. Am. J. Vet. Res. 54:1993;1411-1414.
37. Rose M.L., Semrad S.D. Clinical efficacy of tirilazad mesylate for treatment of endotoxemia in neonatal calves. Am. J. Vet. Res. 53:1992;2305-2310.
38. Roth J., McClellan J.L., Kluger M.J., Zeisberger E. Attenuation of fever and release of cytokines after repeated injection of lipopolysaccharide in guinea-pigs. J. Physiol. 477:1994;177-185.
39. Sanchez-Cantu L., Rode H.N., Chrostov N.V. Endotoxin tolerance is associated with the reduced secretion of tumor necrosis factor. Arch. Surg. 124:1989;1432-1436.
40. Sheppard B.C., Norton J.A. Tumor necrosis factor and interleukin-1 protection against the lethal effect of tumor necrosis factor. Surgery. 106:1991;698-705.
41. Sloane P.J., Elsasser T.H., Spath J.A., Albertine K.H., Gee M.H. Plasma tumor necrosis factor-alpha during long-term endotoxemia in awake sheep. J. Appl. Physiol. 73:1992;1831-1837.
42. Tracey K.J., Beutler B., Lowry S.F., Merryweather J., Wolpe S., Milsark I.W., Hariri R.J., Fahey T.J., Zentella A., Albert J.D., Shires G.T., Cerami A. Shock and tissue injury induced by recombinant human cachectin. Science. 234:1986;40-44.
43. Tracey K.J., Fong Y., Hesse D.G. Anti-cachectin TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature. 330:1987;662-664.
44. Tzung S.P., Mahl T.C., Lance P., Andersen V., Cohen S.A. Interferon-α prevents endotoxin induced mortality in mice. Eur. J. Immunol. 22:1992;3097-3101.
45. Vogel, S.N., 1992. Lipopolysaccharide induced interferons. In: Ryan, J.L., Morrison, C.D. (Eds.), Bacterial Endotoxic Lipopolysaccharides, Vol. 2. Immunopharmacology and Pathophysiology of LPS. CRC Press, Boca Raton, FL, pp. 165-195.
46. Witek-Janusek L., Filkuins J.P. Insulin-like action of endotoxin: antagonism by steroidal and nonsteroidal anti-inflammatory agents. Circ. Shock. 8:1981;573-583.
47. Youngner J.S., Feingold D.S., Chen J.K. Involvement of chemical moiety of bacterial lipopolysaccharide in production of interferon on animals. J. Infect. Dis. 128:1973;227-231.
48. Zaczyńska E., Broniarek E., Błach-Olszewska Z. Spontaneous and lipopolysaccharide-induced tumor necrosis factor alpha and interferon beta production by resident peritoneal cells of mice: effect of sex, age and strain. Arch. Immunol. Ther. Exp. 41:1993;67-71.
49. Zaldivar N.M., Scher I. Endotoxin lethality and tolerance in mice: analysis with the B-lymphocyte-defective CBA/N strain. Infect. Immunol. 24:1979;127-131.